EGLN1 and neoplasm: The patient harboring the H374R mutant originally presented with erythrocytosis, but a tumor matching the characteristics of a paraganglioma was later diagnosis at 43 years old (Ladroue et al., 2008) This individual displayed loss of the remaining wild-type EGLN1 allele.